Compare MAMA & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAMA | AQST |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 602.1M | 529.4M |
| IPO Year | 2011 | 2007 |
| Metric | MAMA | AQST |
|---|---|---|
| Price | $15.60 | $5.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $19.00 | $9.00 |
| AVG Volume (30 Days) | 480.1K | ★ 3.8M |
| Earning Date | 04-14-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.44 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $95,420,129.00 | $67,430,000.00 |
| Revenue This Year | $31.09 | $10.08 |
| Revenue Next Year | $16.12 | $49.60 |
| P/E Ratio | $324.60 | ★ N/A |
| Revenue Growth | ★ 95.54 | 0.77 |
| 52 Week Low | $8.67 | $2.94 |
| 52 Week High | $21.00 | $7.55 |
| Indicator | MAMA | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 37.38 | 68.50 |
| Support Level | $15.51 | $3.70 |
| Resistance Level | $16.19 | $6.66 |
| Average True Range (ATR) | 0.72 | 0.27 |
| MACD | -0.09 | 0.07 |
| Stochastic Oscillator | 6.20 | 86.80 |
Mama's Creations Inc manufactures and markets fresh deli-prepared foods distributed through grocery, mass, club, and convenience stores across the United States. Its product portfolio includes refrigerated prepared foods such as meatballs, meatloaf, sausage products, and pasta and rice entrees. The products are principally sold to supermarkets, club chains, mass-market retailers, and food distributors. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.